Dr Amarnath Challapalli

  • MBBS, MD (Radiotherapy), MRCP-UK,FRCR, Ph.D
  • Consultant Clinical Oncologist and Honorary Senior Lecturer

Overview

Clinical interests

Radiotherapy, Chemotherapy, Immunotherapy, Radio-isotope therapy

Professional memberships

  • Royal College of Radiologists, London   
  • British Uro-Oncology Group 

Research interests

His research interests include functional imaging for urological cancers, stereotactic radiotherapy, brachytherapy, image guidance and exploring chemotherapy & immunotherapy combinations.

He is the UK Chief Investigator for the adjuvant Cemiplimab trial in high risk squamous cell carcinoma and a Co-Chief Investigator of the national multicentre ACE trial.